文献速递乳腺MR乳腺X线

患者对乳腺癌筛查中使用增强成像的偏好调查

Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening.
PubMed 文献 · Acad Radiol · 2021-04-09

该研究通过匿名问卷调查了单中心接受乳腺X线筛查的患者对CEM或MRI作为筛查方式的偏好。共1011例完成调查,多数对辐射、对比剂过敏、静脉置管、幽闭恐惧和假阳性不关心或中立;53.0%报告致密乳腺,其中47.6%接受额外筛查;54.7%愿意为筛查MRI支付至少250-500美元。致密乳腺者更不满意X线筛查且更愿支付MRI费用。

要点

  • 致密乳腺患者对X线筛查满意度更低,更愿意为MRI付费。
  • 有CEM/MRI经历者较少担心过敏、置管和幽闭恐惧。
  • 多数患者对增强筛查的辐射、过敏、假阳性等风险持中立或不关心态度。

诊断标准与关键数值

  • 53.0%报告致密乳腺,其中47.6%接受额外筛查。
  • 49.6%有召回经历,29.0%良性活检,13.7%既往CEM/MRI。
  • 34.7%对乳腺X线筛查满意。
  • 54.7%愿意为筛查MRI支付至少250-500美元。
  • 致密乳腺者更不满意X线筛查(p<0.001)且更愿为MRI付费(p<0.001)。

临床应用与阅片要点

  • 与致密乳腺患者沟通筛查方案时可提及其对MRI的支付意愿较高。
  • 有CEM/MRI经历者对新检查接受度更高,可减少对过敏、置管等的担忧。
  • 患者对辐射、过敏、假阳性等风险多持中立态度,沟通时可侧重获益。

局限性

  • 单中心调查,结果外推需谨慎。
  • 为问卷调查,存在应答偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Our purpose is to understand patient preferences towards contrast-enhanced imaging such as CEM or MRI for breast cancer screening.

METHODS AND MATERIALS: An anonymous survey was offered to all patients having screening mammography at a single academic institution from December 27 th 2019 to March 6 th 2020. Survey questions related to: (1) patients' background experiences (2) patients' concern for aspects of MRI and CEM measured using a 5-point Likert scale, and (3) financial considerations.

RESULTS: 75% (1011/1349) patients completed the survey. 53.0% reported dense breasts and of those, 47.6% had additional screening. 49.6% had experienced a callback, 29.0% had a benign biopsy, and 13.7% had prior CEM/MRI. 34.7% were satisfied with mammography for screening. A majority were neutral or not concerned with radiation exposure, contrast allergy, IV line placement, claustrophobia, and false positive exams. 54.7% were willing to pay at least $250-500 for screening MRI. Those reporting dense breasts were less satisfied with mammography for screening (p<0.001) and willing to pay more for MRI (p<0.001). If patients had prior CEM/MRI, there was less concern for an allergic reaction (p<0.001), IV placement (p=0.025), and claustrophobia (p=0.006). There was less concern for false positives if they had a prior benign biopsy (p=0.029) or prior CEM/MRI (p=0.005) and less concern for IV placement if they had dense breasts (p=0.007) or a previous callback (p=0.013).

CONCLUSION: The screening population may accept CEM or MRI as a screening exam despite its risks and cost, especially patients with dense breasts and patients who have had prior CEM/MRI.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Son D, Phillips J, Mehta TS, et al. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening. Acad Radiol. 2021. PMID: 33846061. doi:10.1016/j.acra.2021.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。